-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Inventing the Future of Allogeneic CAR T-Cell Therapies through Gene Editing

Program: Scientific Workshops @ ASH
Session: CAR-T and Other Cellular Therapy for Mutiple Myeloma
Thursday, December 3, 2020, 9:12 AM-9:57 AM

Carrie Brownstein, MD

Cellectis, New York, NY

Disclosures: No relevant conflicts of interest to declare.